Clinical trial
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic…
NCT00412529 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00412529 |
|---|---|
| Title | Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B |
| Official title | A Randomized, Open-label, Controlled, Multicenter, Exploratory Trial to Characterize the Results of Daily Oral Administration of Telbivudine (LDT600) 600 mg or Entecavir (ETV) 0.5 mg Given Over 12 Weeks on the Kinetics of Hepatitis B Virus (HBV) DNA in Adults With HBeAg-positive, Compensated Chronic… |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Entecavir, Telbivudine |
| Enrollment | 44 |
| Start date | Dec 1, 2006 |
| Primary completion | Feb 1, 2008 |
| First posted | Dec 18, 2006 |
| Last update posted | Mar 13, 2015 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: